Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 76

1.

[Sometimes a liver can cause you headaches - case 4/2014].

Müller NF, Lauer UM, Horger M, Malek NP, Berg CP.

Dtsch Med Wochenschr. 2014 Jun;139(25-26):1352. doi: 10.1055/s-0034-1370149. Epub 2014 Jun 25. German.

PMID:
24964252
[PubMed - in process]
Free Article
2.

Pulsed versus continuous application of the prodrug 5-fluorocytosine to enhance the oncolytic effectiveness of a measles vaccine virus armed with a suicide gene.

Yurttas C, Berchtold S, Malek NP, Bitzer M, Lauer UM.

Hum Gene Ther Clin Dev. 2014 Jun;25(2):85-96. doi: 10.1089/humc.2013.127.

PMID:
24933569
[PubMed - in process]
3.

"PULSED" versus "CONTINUOUS" application of the prodrug 5-FC for enhancing oncolytic effectiveness of a measles vaccine virus armed with a suicide gene.

Yurttas C, Berchtold S, Malek N, Bitzer M, Lauer UM.

Hum Gene Ther Clin Dev. 2014 Apr 21. [Epub ahead of print]

PMID:
24749489
[PubMed - as supplied by publisher]
4.

Efficacy and safety of telaprevir (TVR) triple therapy in a 'real-life' cohort of 102 patients with HCV genotype 1: interim analysis after 24 weeks of treatment.

Werner CR, Franz C, Egetemeyr DP, Janke-Maier P, Malek NP, Lauer UM, Berg CP.

J Viral Hepat. 2014 May;21(5):333-40. doi: 10.1111/jvh.12145. Epub 2013 Aug 5.

PMID:
24716636
[PubMed - in process]
5.

Attenuated and protease-profile modified sendai virus vectors as a new tool for virotherapy of solid tumors.

Zimmermann M, Armeanu-Ebinger S, Bossow S, Lampe J, Smirnow I, Schenk A, Lange S, Weiss TS, Neubert W, Lauer UM, Bitzer M.

PLoS One. 2014 Mar 5;9(3):e90508. doi: 10.1371/journal.pone.0090508. eCollection 2014.

PMID:
24598703
[PubMed - in process]
Free PMC Article
6.

[An unexpected cause of progressive hepatopathy - Case 2/2014].

Federmann B, Lauer UM, Haen S, Kilias A, Artunc F, Riessen R, Fend F, Haap M.

Dtsch Med Wochenschr. 2014 Feb;139(8):378. doi: 10.1055/s-0033-1360047. Epub 2014 Feb 11. German. No abstract available.

PMID:
24519115
[PubMed - indexed for MEDLINE]
7.

Treatment of recurrent genotype 1 hepatitis C post-liver transplantation: single center experience with telaprevir-based triple therapy.

Werner CR, Egetemeyr DP, Nadalin S, Königsrainer A, Malek NP, Lauer UM, Berg CP.

Z Gastroenterol. 2014 Jan;52(1):27-34. doi: 10.1055/s-0033-1356345. Epub 2014 Jan 13.

PMID:
24420796
[PubMed - in process]
8.

Feasibility of telaprevir-based triple therapy in liver transplant patients with hepatitis C virus: SVR 24 results.

Werner CR, Egetemeyr DP, Lauer UM, Nadalin S, Königsrainer A, Malek NP, Berg CP.

PLoS One. 2013 Nov 12;8(11):e80528. doi: 10.1371/journal.pone.0080528. eCollection 2013.

PMID:
24265827
[PubMed - in process]
Free PMC Article
9.

Correction: Resveratrol as a Pan-HDAC Inhibitor Alters the Acetylation Status of Jistone Proteins in Human-Derived Hepatoblastoma Cells.

Venturelli S, Berger A, Böcker A, Busch C, Weiland T, Noor S, Leischner C, Schleicher S, Mayer M, Weiss TS, Bischoff SC, Lauer UM, Bitzer M.

PLoS One. 2013 Sep 4;8(9). doi: 10.1371/annotation/5b9a8614-1009-40ca-b90b-db817fe445c9. eCollection 2013.

PMID:
24039676
[PubMed - as supplied by publisher]
Free PMC Article
10.

Resveratrol as a pan-HDAC inhibitor alters the acetylation status of jistone proteins in human-derived hepatoblastoma cells.

Venturelli S, Berger A, Böcker A, Busch C, Weiland T, Noor S, Leischner C, Schleicher S, Mayer M, Weiss TS, Bischoff SC, Lauer UM, Bitzer M.

PLoS One. 2013 Aug 30;8(8):e73097. doi: 10.1371/journal.pone.0073097. eCollection 2013.

PMID:
24023672
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Optical detection and virotherapy of live metastatic tumor cells in body fluids with vaccinia strains.

Wang H, Chen NG, Minev BR, Zimmermann M, Aguilar RJ, Zhang Q, Sturm JB, Fend F, Yu YA, Cappello J, Lauer UM, Szalay AA.

PLoS One. 2013 Sep 3;8(9):e71105. doi: 10.1371/journal.pone.0071105. eCollection 2013.

PMID:
24019862
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Differential induction of apoptosis and senescence by the DNA methyltransferase inhibitors 5-azacytidine and 5-aza-2'-deoxycytidine in solid tumor cells.

Venturelli S, Berger A, Weiland T, Essmann F, Waibel M, Nuebling T, Häcker S, Schenk M, Schulze-Osthoff K, Salih HR, Fulda S, Sipos B, Johnstone RW, Lauer UM, Bitzer M.

Mol Cancer Ther. 2013 Oct;12(10):2226-36. doi: 10.1158/1535-7163.MCT-13-0137. Epub 2013 Aug 7.

PMID:
23924947
[PubMed - indexed for MEDLINE]
13.

Enhanced killing of therapy-induced senescent tumor cells by oncolytic measles vaccine viruses.

Weiland T, Lampe J, Essmann F, Venturelli S, Berger A, Bossow S, Berchtold S, Schulze-Osthoff K, Lauer UM, Bitzer M.

Int J Cancer. 2014 Jan 1;134(1):235-43. doi: 10.1002/ijc.28350. Epub 2013 Aug 7.

PMID:
23797800
[PubMed - indexed for MEDLINE]
14.

An armed oncolytic measles vaccine virus eliminates human hepatoma cells independently of apoptosis.

Lampe J, Bossow S, Weiland T, Smirnow I, Lehmann R, Neubert W, Bitzer M, Lauer UM.

Gene Ther. 2013 Nov;20(11):1033-41. doi: 10.1038/gt.2013.28. Epub 2013 May 30.

PMID:
23719065
[PubMed - indexed for MEDLINE]
15.

Intrahepatic application of suicide gene-armed measles virotherapeutics: a safety study in transgenic mice and rhesus macaques.

Völker I, Bach P, Coulibaly C, Plesker R, Abel T, Seifried J, Heidmeier S, Mühlebach MD, Lauer UM, Buchholz CJ.

Hum Gene Ther Clin Dev. 2013 Mar;24(1):11-22. doi: 10.1089/humc.2012.242. Epub 2013 Apr 3.

PMID:
23692379
[PubMed - indexed for MEDLINE]
16.

Enhanced killing of ovarian carcinoma using oncolytic measles vaccine virus armed with a yeast cytosine deaminase and uracil phosphoribosyltransferase.

Hartkopf AD, Bossow S, Lampe J, Zimmermann M, Taran FA, Wallwiener D, Fehm T, Bitzer M, Lauer UM.

Gynecol Oncol. 2013 Aug;130(2):362-8. doi: 10.1016/j.ygyno.2013.05.004. Epub 2013 May 12.

PMID:
23676551
[PubMed - indexed for MEDLINE]
17.

Primary resistance phenomena to oncolytic measles vaccine viruses.

Noll M, Berchtold S, Lampe J, Malek NP, Bitzer M, Lauer UM.

Int J Oncol. 2013 Jul;43(1):103-12. doi: 10.3892/ijo.2013.1914. Epub 2013 Apr 23.

PMID:
23612727
[PubMed - indexed for MEDLINE]
18.

A novel armed oncolytic measles vaccine virus for the treatment of cholangiocarcinoma.

Lange S, Lampe J, Bossow S, Zimmermann M, Neubert W, Bitzer M, Lauer UM.

Hum Gene Ther. 2013 May;24(5):554-64. doi: 10.1089/hum.2012.136.

PMID:
23550539
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Innate immune defense defines susceptibility of sarcoma cells to measles vaccine virus-based oncolysis.

Berchtold S, Lampe J, Weiland T, Smirnow I, Schleicher S, Handgretinger R, Kopp HG, Reiser J, Stubenrauch F, Mayer N, Malek NP, Bitzer M, Lauer UM.

J Virol. 2013 Mar;87(6):3484-501. doi: 10.1128/JVI.02106-12. Epub 2013 Jan 9.

PMID:
23302892
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Specific elimination of CD133+ tumor cells with targeted oncolytic measles virus.

Bach P, Abel T, Hoffmann C, Gal Z, Braun G, Voelker I, Ball CR, Johnston IC, Lauer UM, Herold-Mende C, Mühlebach MD, Glimm H, Buchholz CJ.

Cancer Res. 2013 Jan 15;73(2):865-74. doi: 10.1158/0008-5472.CAN-12-2221. Epub 2013 Jan 4.

PMID:
23293278
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk